M C Favrot|V Combaret|C Lasset - JoVE Visualize

Showing results (1-10 of 146) with videos related to

Pageof 15

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996

Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomasV Combaret, N Gross, C Lasset, et al.

European Journal of Cancer (Oxford, England : 1990)|March 28, 1998

Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastomaV Combaret, N Gross, C Lasset, et al.

Bulletin Du Cancer|January 1, 1995

[CD44 expression: a new prognostic factor in neuroblastoma]V Combaret, C Lasset, R Bouvier, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1995

Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factorsV Combaret, C Lasset, D Frappaz, et al.

Pathologie-Biologie|January 1, 1988

[The significance of immunological analysis for the detection of residual neuroblasts in bone marrow]O Maritaz, V Combaret, M C Favrot

Invasion & Metastasis|January 1, 1994

Expression of integrin and CD44 adhesion molecules on neuroblastoma: the relation to tumor aggressiveness and embryonic neural-crest differentiationV Combaret, J L Coll, M C Favrot

Bulletin Du Cancer|September 30, 1998

[Biological markers for the prognosis of neuroblastoma: proposal of a method of analysis]V Combaret, O Delattre, J Bénard, et al.

British Journal of Cancer|January 1, 1997

Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expressionV Combaret, N Gross, C Lasset, et al.

Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|June 1, 1990

[Evaluation of a modified immunomagnetic procedure for the purging of neuroblastoma cells from bone marrow]B Kremens, V Combaret, M C Favrot, et al.

Bone Marrow Transplantation|May 1, 1988

S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograftV Combaret, B Kremens, M C Favrot, et al.

Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:

Pageof 15

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996

Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomasV Combaret, N Gross, C Lasset, et al.

European Journal of Cancer (Oxford, England : 1990)|March 28, 1998

Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastomaV Combaret, N Gross, C Lasset, et al.

Bulletin Du Cancer|January 1, 1995

[CD44 expression: a new prognostic factor in neuroblastoma]V Combaret, C Lasset, R Bouvier, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1995

Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factorsV Combaret, C Lasset, D Frappaz, et al.

Pathologie-Biologie|January 1, 1988

[The significance of immunological analysis for the detection of residual neuroblasts in bone marrow]O Maritaz, V Combaret, M C Favrot

Invasion & Metastasis|January 1, 1994

Expression of integrin and CD44 adhesion molecules on neuroblastoma: the relation to tumor aggressiveness and embryonic neural-crest differentiationV Combaret, J L Coll, M C Favrot

Bulletin Du Cancer|September 30, 1998

[Biological markers for the prognosis of neuroblastoma: proposal of a method of analysis]V Combaret, O Delattre, J Bénard, et al.

British Journal of Cancer|January 1, 1997

Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expressionV Combaret, N Gross, C Lasset, et al.

Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|June 1, 1990

[Evaluation of a modified immunomagnetic procedure for the purging of neuroblastoma cells from bone marrow]B Kremens, V Combaret, M C Favrot, et al.

Bone Marrow Transplantation|May 1, 1988

S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograftV Combaret, B Kremens, M C Favrot, et al.

Pageof 15